Logo Logo

Publications by Tabernero, Josep

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 3.

Journal article

Cohn, Allen Lee; Yoshino, Takayuki; Heinemann, Volker; Obermannova, Radka; Bodoky, Gyorgy; Prausova, Jana; Garcia-Carbonero, Rocio; Ciuleanu, Tudor; Garcia-Alfonso, Pilar; Portnoy, David C.; Cutsem, Eric van; Yamazaki, Kentaro; Clingan, Philip R.; Polikoff, Jonathon; Lonardi, Sara; O'Brien, Lisa M.; Gao, Ling; Yang, Ling; Ferry, David; Nasroulah, Federico; Tabernero, Josep (2017): Exposure-response relationship of ramucirumab in patients with advanced second-line colorectal cancer: exploratory analysis of the RAISE trial. In: Cancer Chemotherapy and Pharmacology, Vol. 80, No. 3: pp. 599-608 [PDF, 1MB]

Tejpar, Sabine; Stintzing, Sebastian; Ciardiello, Fortunato; Tabernero, Josep; Cutsem, Eric van; Beier, Frank; Esser, Regina; Lenz, Heinz-Josef; Heinemann, Volker (2017): Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer Retrospective Analyses of the CRYSTAL and FIRE-3 Trials. In: Jama Oncology, Vol. 3, No. 2: pp. 194-201

Cutsem, Eric van; Lenz, Heinz-Josef; Furuse, Junji; Tabernero, Josep; Heinemann, Volker; Ioka, Tatsuya; Bazin, Igor; Ueno, Makoto; Csõszi, Tibor; Wasan, Harpreet; Melichar, Bohuslav; Karasek, Petr; Macarulla, Teresa; Ponce, Carmen Guillen; Kalinka-Warzocha, Ewa; Horvath, Zsolt; Prenen, Hans; Schlichting, Michael; Mehdi, Fazal; Bendell, Johanna C. (2016): Evofosfamide (TH-302) in combination with gemcitabine in previously untreated patients with metastatic or locally advanced unresectable pancreatic ductal adenocarcinoma: Primary analysis of the randomized, double-blind phase III MAESTRO study. In: Journal of Clinical Oncology, Vol. 34, No. 4

This list was generated on Mon Aug 10 11:08:05 2020 CEST.